299 related articles for article (PubMed ID: 24218336)
1. Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis.
Han L; Chen W; Zhao Q
Tumour Biol; 2014 Mar; 35(3):2473-80. PubMed ID: 24218336
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumor cells in peripheral blood of pancreatic cancer patients and their prognostic role: a systematic review and meta-analysis.
Wang Y; Yu X; Hartmann D; Zhou J
HPB (Oxford); 2020 May; 22(5):660-669. PubMed ID: 31786054
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
4. Relationship between circulating tumor cells and tumor response in colorectal cancer patients treated with chemotherapy: a meta-analysis.
Huang X; Gao P; Song Y; Sun J; Chen X; Zhao J; Liu J; Xu H; Wang Z
BMC Cancer; 2014 Dec; 14():976. PubMed ID: 25519477
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Circulating Tumor Cells in Ovarian Cancer: A Meta-Analysis.
Zhou Y; Bian B; Yuan X; Xie G; Ma Y; Shen L
PLoS One; 2015; 10(6):e0130873. PubMed ID: 26098665
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of circulating tumor cells associated with white blood cells in solid cancer: a systematic review and meta-analysis of 1471 patients with solid tumors.
Ju M; Gao Z; Gu G; Huang H; Sun A; Zheng C; Li H; Zhang Y; Li K
BMC Cancer; 2023 Dec; 23(1):1224. PubMed ID: 38087278
[TBL] [Abstract][Full Text] [Related]
7. The significant prognostic value of circulating tumor cells in colorectal cancer: A systematic review and meta-analysis.
Tan Y; Wu H
Curr Probl Cancer; 2018; 42(1):95-106. PubMed ID: 29277243
[TBL] [Abstract][Full Text] [Related]
8. Predictive and prognostic roles of ribonucleotide reductase M1 in patients with pancreatic cancer treated with gemcitabine: a meta-analysis.
Zhang X; Jin FS; Zhang LG; Chen RX; Zhao JH; Wang YN; Wang EF; Jiang ZD
Asian Pac J Cancer Prev; 2013; 14(7):4261-5. PubMed ID: 23991987
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis.
Fang Z; Meng Q; Zhang B; Shi S; Liu J; Liang C; Hua J; Yu X; Xu J; Wang W
Aging (Albany NY); 2020 Dec; 13(2):2031-2048. PubMed ID: 33318293
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of circulating tumor cells in patients with bladder cancer: A meta-analysis.
Jiang H; Gu X; Zuo Z; Tian G; Liu J
PLoS One; 2021; 16(7):e0254433. PubMed ID: 34242363
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of the prognostic value of circulating tumor cells in breast cancer.
Zhang L; Riethdorf S; Wu G; Wang T; Yang K; Peng G; Liu J; Pantel K
Clin Cancer Res; 2012 Oct; 18(20):5701-10. PubMed ID: 22908097
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of circulating tumor cells for the diagnosis and prognosis of hepatocellular carcinoma (HCC): A systematic review and meta-analysis.
Cui K; Ou Y; Shen Y; Li S; Sun Z
Medicine (Baltimore); 2020 Oct; 99(40):e22242. PubMed ID: 33019399
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cells predict survival benefit from chemotherapy in patients with lung cancer.
Wu ZX; Liu Z; Jiang HL; Pan HM; Han WD
Oncotarget; 2016 Oct; 7(41):67586-67596. PubMed ID: 27588489
[TBL] [Abstract][Full Text] [Related]
14. K-Ras mutation detection in liquid biopsy and tumor tissue as prognostic biomarker in patients with pancreatic cancer: a systematic review with meta-analysis.
Li T; Zheng Y; Sun H; Zhuang R; Liu J; Liu T; Cai W
Med Oncol; 2016 Jul; 33(7):61. PubMed ID: 27225938
[TBL] [Abstract][Full Text] [Related]
15. Significant prognostic value of circulating tumor cells in esophageal cancer patients: A meta-analysis.
Wang S; Du H; Li G
Oncotarget; 2017 Feb; 8(9):15815-15826. PubMed ID: 28178659
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer.
Earl J; Garcia-Nieto S; Martinez-Avila JC; Montans J; Sanjuanbenito A; Rodríguez-Garrote M; Lisa E; Mendía E; Lobo E; Malats N; Carrato A; Guillen-Ponce C
BMC Cancer; 2015 Oct; 15():797. PubMed ID: 26498594
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis.
Orhan A; Vogelsang RP; Andersen MB; Madsen MT; Hölmich ER; Raskov H; Gögenur I
Eur J Cancer; 2020 Jun; 132():71-84. PubMed ID: 32334338
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of circulating tumor cells in patients with pancreatic cancer: a meta-analysis.
Ma XL; Li YY; Zhang J; Huang JW; Jia HY; Liu L; Li P
Asian Pac J Cancer Prev; 2014; 15(15):6015-20. PubMed ID: 25124566
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis.
Yang JJ; Hu ZG; Shi WX; Deng T; He SQ; Yuan SG
World J Gastroenterol; 2015 Mar; 21(9):2807-15. PubMed ID: 25759553
[TBL] [Abstract][Full Text] [Related]
20. Common variants in the PALB2 gene confer susceptibility to breast cancer: a meta-analysis.
Zhang YX; Wang XM; Kang S; Li X; Geng J
Asian Pac J Cancer Prev; 2013; 14(12):7149-54. PubMed ID: 24460267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
